News Update: Icagen Soars on Positive Study Results for ICA-105665 Epilepsy Treatment Compound

News Update: Icagen Soars on Positive Study Results for ICA-105665 Epilepsy Treatment Compound — 3/16/2010-Shares of Icagen (NASDAQ:ICGN) are trading 40.5% higher to .76 Tuesday after the company reported positive results in its Phase IIa epilepsy stud…

More Drug Treatment News 2010 Information…